beckman coulter - new troponin test

* From the wholesale investor video and the recent quarterly we know that there is testing that has been taking place on an new " Ultra sensitive blood test " to replace the existing in market

http://www.wholesaleinvestor.com.au/opportunities/anteo_diagnostics_limited_asxado/196/videos

* In the video dated 5th April 2011 he mentions the ultrasensitive tests to be Troponin and Calcitonin

* We also know from slide 7 of the powerpoint presentation that went with this video that the IVD Test manufacturers/Suppliers that are testing mixngo in house are Roche Diagnostics and Beckman Coulter

* From what I can find Beckman Coulter have been working with Anteo/Biolayer since about 2007

* There seems to be a lot happening in the Troponin testing area at the moment - Google - Beckman Troponin test

* Beckmans previous test was not sensitive enough and gave inaccurate results and from what I gather has cost them a lot of money in lost sales

* They are still waiting for FDA approval for the new test and this is in recent news articles as Danaher Corporation has tendered a takeover offer for Beckman Coulter for $6.8 billion

* "Troponin is a small part of Beckmans sales making up about $60 million of about $3 billion in annual revenue but is believed to be highly profitable".

* http://www.ocbj.com/news/2011/may/01/beckman-delays-filings-recall-heart-test/

* Could the exciting results received last week be the completion of this new troponin test ready to be filed for FDA approval?

* Just to speculate on figures - Anteo Annual cash burn $2.5million

* Troponin test with Beckman Coulter worth $60 million annually - Im only guestimating but a 5% annual royalty on that 1 test $3million

= Cash Flow Positive

Is this the MixnGo launching test?